Rolinsatamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Rolinsatamab Usage And Synthesis

Uses

Rolinsatamab is a IgG1κ type chimeric antibody targeting to PRLR (prolactin receptor). Rolinsatamab can be conjugated with pyrrolobenzodiazepine (PDB) dimer SGD-1882 (HY-101127) via a cleavable maleimidocaproyl type linker, to form an antibody-drug conjugate, Rolinsatamab talirine. One Rolinsatamab talirine has an average of 2 site-specific drug attachment engineered cysteines (S239C). The linker equips the valine-alanine dipeptide, as cathepsine B cleavage site. on an average of 2 site-specific drug attachment engineered cysteines (S239C)[1].

References

[1] Anderson MG, et al. ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. BMC Cancer. 2021 Jun 9;21(1):681. DOI:10.1186/s12885-021-08403-5

Rolinsatamab(2095467-30-2)Related Product Information

• Pacmilimab
• Cetrelimab
• Varisacumab
• Sotrovimab
• Enavatuzumab
• Landogrozumab
• Camrelizumab
• Glofitamab
• Ixekizumab
• catumaxomab